T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,985 | 1,952 | 2,061 | 1,679 | 1,472 |
| Cost of Goods | 4,101 | 2,693 | 4,202 | 2,574 | 3,925 |
| Gross Profit | -2,116 | -741 | -2,141 | -895 | -2,453 |
| Operating Expenses | 8,146 | 9,527 | 10,661 | 8,998 | 12,079 |
| Operating Income | -10,161 | -9,575 | -12,600 | -9,319 | -13,607 |
| Interest Expense | 370 | 478 | 1,179 | 1,161 | 1,119 |
| Other Income | 414 | 1,090 | 245 | 140 | -699 |
| Pre-tax Income | -10,117 | -8,963 | -13,534 | -10,340 | -15,425 |
| Net Income Continuous | -10,117 | -8,963 | -13,534 | -10,340 | -15,425 |
| Net Income | $-10,117 | $-8,963 | $-13,534 | $-10,340 | $-15,425 |
| EPS Basic Total Ops | -0.57 | -0.64 | -2.66 | 123.87 | -3.45 |
| EPS Basic Continuous Ops | -0.57 | -0.64 | -2.66 | 123.88 | -3.45 |
| EPS Diluted Total Ops | -0.57 | -0.64 | -2.66 | 123.87 | -3.45 |
| EPS Diluted Continuous Ops | -0.57 | -0.64 | -2.66 | 123.88 | -3.45 |
| EPS Diluted Before Non-Recurring Items | -0.57 | -0.66 | -2.66 | N/A | -3.45 |
| EBITDA(a) | $-10,102 | $-9,513 | $-12,536 | $-9,245 | $-13,345 |